Charming Medical Limited Class A Ordinary Shares Cash Flow Reinvestment Rate

Latest as of March 2025: 5.91x

Charming Medical Limited Class A Ordinary Shares cash flow reinvestment rate. Charming Medical Limited Class A Ordinary Shares (MCTA) has a Cash Flow Reinvestment Rate of 5.91x as of March 2025, reinvesting $2.52 Million (capex $287.53K plus investments $-2.23 Million) from operating cash flow of $425.89K. See MCTA financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

5.91x
(Capex + Investments) / Operating CF

Total Reinvested

$2.52 Million
Capex + Investments

Operating Cash Flow

$425.89K
USD

Capital Expenditures

$287.53K
USD

Cash Flow Reinvestment Rate of Charming Medical Limited Class A Ordinary Shares (2023–2025)

Cash flow reinvestment rate of Charming Medical Limited Class A Ordinary Shares from 2023 to 2025. Historical reinvestment intensity for Charming Medical Limited Class A Ordinary Shares across 3 annual periods. Explore MCTA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Charming Medical Limited Class A Ordinary Shares Cash Flow Reinvestment Rate by Year (2023–2025)

Charming Medical Limited Class A Ordinary Shares cash flow reinvestment rate by year from 2023 to 2025. Year-by-year capital reinvestment analysis for Charming Medical Limited Class A Ordinary Shares. For the full cash flow conversion analysis, see MCTA cash flow metrics.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 5.91x $2.52 Million $425.89K $287.53K ▲ +314.5%
2024 1.43x $421.20K $295.43K $210.60K ▲ +186.2%
2023 0.50x $1.21 Million $2.43 Million $606.19K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow